|
|
 |
PathVysion® HER-2 DNA Probe Kit | | | General Information | |
| Vendor | | Vysis, Inc. | | Item | | PathVysion® HER-2 DNA Probe Kit | | Features | | - It is a precise test that provides clinicians and their patients with the most accurate and reliable HER-2 status information available for making critical decisions towards therapy that improves survival rates and the quality of life for breast cancer patients.
| | Approval | | US FDA | | Product Number | | Inquire | | Analysis Time | | Inquire | | Sensitivity | | Inquire | | Instrumentation Needed | | Inquire | | Test Method | | FISH-based DNA probe | | Number of Tests | | Inquire | | Pricing |  | Inquire |
| | Product Description | |
| PathVysion is the only HER-2 assessment test approved by the U.S Food and Drug Administration (FDA) for three claims: prognosis, adriamycin-based chemotherapy selection and Herceptin® (Trastuzumab) monoclonal antibody therapy selection. PathVysion is the only FISH-based DNA probe HER-2 test listed in the Herceptin® package insert as an appropriate test to aid in the selection of patients for Herceptin® therapy. | |
| Vysis, Inc. | | Customer Service: (800) 553-7042 | | Web site: http://www.vysis.com/ | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
